Does industry need a preclinical database? Robert Califf says yes

FDA Commissioner Robert M. Califf, M.D., has suggested that establishing a government-sponsored database of preclinical studies could improve transparency in drug development and the ability of researchers to reproduce study results. Califf, who made his comments at an event co-sponsored by the National Library of Medicine, said that data from preclinical studies, including work that both succeeded and failed, could be made publicly available on a website similar to ClinicalTrials.gov, a federally mandated registry and results database of clinical research trials conducted in the U.S. and around the world.

New partnership reflects growing joint efforts in advancing precision medicine research

As the research industry marches with longer strides toward tailored medi­cal treatments, a new partnership between Thermo Fisher Scientific and West China Hospital of Sichuan University to de­velop a joint precision medicine research plat­form is the latest herald of an era of greater cooperation between diverse partners.

To read the full articles for this issue of The CenterWatch Weekly, please click here for subscription information.